Endogastric Solutions Inc. (EGS), a Redmond, Wash.-based company developing an incisionless surgical technology to treat gastroesophageal reflex disease (GERD), raised $45 million in Series I financing, thanks to a late, $14.5 million shot in the arm from Israeli-based med-tech investment firm Accelmed Growth Partners. Read More
